Amphastar Pharmaceuticals, Inc.

Amphastar has revealed plans for a “multi-year expansion of its US manufacturing operations” at its headquarters in Rancho Cucamonga, California, with the firm planning to quadruple production capacit

For the third time, the US Federal Trade Commission has sent warning letters to drug companies, disputing improperly listed patents in the US Food and Drug Administration’s Orange Book. The agency tar

For the third time, the Federal Trade Commission has sent out warning letters to drug companies, disputing improperly listed patents in the US Food and Drug Administration’s Orange Book. In this round

Last week’s J.P. Morgan Healthcare Conference in San Francisco generated multiple headlines for the generics and biosimilars industry, with Generics Bulletin bringing you dedicated stories on the la